<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02566629</url>
  </required_header>
  <id_info>
    <org_study_id>2015SDU-QILU-G11</org_study_id>
    <nct_id>NCT02566629</nct_id>
  </id_info>
  <brief_title>Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase</brief_title>
  <official_title>Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analyze microbiota community of irritable bowel syndrome in episodes phase and remission
      phase.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The pathophysiology of IBS is incompletely understood, it may involve an altered intestinal
      microbiota. Since the microflora composition of IBS is various in different studies, The
      investigators plan to compare the intestinal microbiota of IBS patients in episodes phase and
      remission phase with healthy controls,trying to find the difference.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>microbiota community among IBS patients in episodes phase,remission phase and healthy controls</measure>
    <time_frame>5 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of life in IBS patients</measure>
    <time_frame>5 months</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>IBS patients in episodes phase</arm_group_label>
    <description>collect faeces from IBS patients in episodes remission phase</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IBS patients in remission phase</arm_group_label>
    <description>collect faeces from IBS patients in remission phase</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy controls</arm_group_label>
    <description>collect faeces from healthy controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collect faeces from participants</intervention_name>
    <description>analyze the fecal microbiota community using 16S rDNA detection technique</description>
    <arm_group_label>IBS patients in episodes phase</arm_group_label>
    <arm_group_label>IBS patients in remission phase</arm_group_label>
    <arm_group_label>healthy controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      extract 16S rDNA from fecal microflora
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients who fulfil the Rome III criteria of irritable bowel syndrome in Qilu Hospital
        outpatient
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  the presence of Rome III criteria for IBS ;

          -  Patients scheduled for colonoscopy examination or having negative screening
             examinations

          -  Aged between 18 and 65 years old

        Exclusion Criteria:

          -  Antibiotic, probiotic or laxative usage within 4 weeks.

          -  organic gastrointestinal diseases

          -  Severe systematic disease: diabetes mellitus, hepatic, renal or cardiac dysfunction,
             thyroid disease or tumor etc.

          -  pregnancy or lactation.

          -  previous major or complicated abdominal surgery.

          -  severe endometriosis and dementia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yanqing Li, MD.PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Qilu Hospital of Shandong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yanqing Li, MD.PhD</last_name>
    <phone>86-531-82169236</phone>
    <phone_ext>86-531-8216923</phone_ext>
    <email>liyanqing@sdu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Gastroenterology, Qilu Hospital, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanqing Li, MD.PHD</last_name>
      <phone>86-531-8216923</phone>
      <phone_ext>86-531-8216923</phone_ext>
      <email>liyanqing@sdu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Jiaxin Du, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2015</study_first_submitted>
  <study_first_submitted_qc>October 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2015</study_first_posted>
  <last_update_submitted>October 1, 2015</last_update_submitted>
  <last_update_submitted_qc>October 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Yanqing Li</investigator_full_name>
    <investigator_title>Vice president of Qilu Hospital</investigator_title>
  </responsible_party>
  <keyword>microbiota community</keyword>
  <keyword>IBS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

